Adjuvant Pembrolizumab in Resected Stage III Melanoma

被引：0
|
作者：
Barker, Christopher A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 593
页数：1
相关论文
共 50 条
  • [1] Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
    Eggermont, Alexander M. M.
    Blank, Christian U.
    Mandala, Mario
    Long, Georgina, V
    Atkinson, Victoria
    Dalle, Stephane
    Haydon, Andrew
    Lichinitser, Mikhail
    Khattak, Adnan
    Carlino, Matteo S.
    Sandhu, Shahneen
    Larkin, James
    Puig, Susana
    Ascierto, Paolo A.
    Rutkowski, Piotr
    Schadendorf, Dirk
    Koornstra, Rutger
    Hernandez-Aya, Leonel
    Maio, Michele
    van den Eertwegh, Alfonsus J. M.
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Jamal, Rahima
    Lorigan, Paul
    Ibrahim, Nageatte
    Marreaud, Sandrine
    van Akkooi, Alexander C. J.
    Suciu, Stefan
    Robert, Caroline
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19): : 1789 - 1801
  • [2] Safety of pembrolizumab for resected stage III melanoma
    Pham, F.
    Dalle, S.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (10) : 1221 - 1227
  • [3] Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)
    Patel, S.
    Othus, M.
    Prieto, V.
    Lowe, M.
    Buchbinder, E.
    Chen, Y.
    Hyngstrom, J.
    Lao, C. D.
    Truong, T-G.
    Chandra, S.
    Kendra, K.
    Devoe, C.
    Hedge, A.
    Mangla, A.
    Sharon, E.
    Korde, L.
    Moon, J.
    Sondak, V.
    Ribas, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1408 - S1408
  • [4] Adjuvant pembrolizumab-related hyperprogression in stage III melanoma
    Ammann, Nadine L.
    Geidel, Glenn
    Schneider, Stefan W.
    Gebhardt, Christoffer
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (09): : 1341 - 1345
  • [5] Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
    Bensimon, Arielle G.
    Zhou, Zheng-Yi
    Jenkins, Madeline
    Song, Yan
    Gao, Wei
    Signorovitch, James
    Krepler, Clemens
    Liu, Frank Xiaoqing
    Wang, Jingshu
    Aguiar-Ibanez, Raquel
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (10) : 981 - 993
  • [6] Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
    Weber, J.
    Mandala, M.
    Del Vecchio, M.
    Gogas, H. J.
    Arance, A. M.
    Cowey, C. L.
    Dalle, S.
    Schenker, M.
    Chiarion-Sileni, V.
    Marquez-Rodas, I.
    Grob, J-J.
    Butler, M. O.
    Middleton, M. R.
    Maio, M.
    Atkinson, V.
    Queirolo, P.
    Gonzalez, R.
    Kudchadkar, R. R.
    Smylie, M.
    Meyer, N.
    Mortier, L.
    Atkins, M. B.
    Long, G. V.
    Bhatia, S.
    Lebbe, C.
    Rutkowski, P.
    Yokota, K.
    Yamazaki, N.
    Kim, T. M.
    de Pril, V.
    Sabater, J.
    Qureshi, A.
    Larkin, J.
    Ascierto, P. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19): : 1824 - 1835
  • [7] Management of resected stage III/IV melanoma with adjuvant immunotherapy.
    Johnson, Rebecca
    Atkinson, Victoria
    Bhave, Prachi
    Weppler, Alison Margaret
    Peters, Geoffrey David
    Abed, Afaf
    Lyle, Megan
    Khattak, Muhammad Adnan
    Haydon, Andrew Mark
    Carlino, Matteo S.
    Sandhu, Shahneen Kaur
    Long, Georgina V.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
    Bensimon, Arielle G.
    Zhou, Zheng-Yi
    Jenkins, Madeline
    Song, Yan
    Gao, Wei
    Signorovitch, James
    Krepler, Clemens
    Scherrer, Emilie
    Wang, Jingshu
    Aguiar-Ibanez, Raquel
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (07) : 629 - 643
  • [9] An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
    Arielle G. Bensimon
    Zheng-Yi Zhou
    Madeline Jenkins
    Yan Song
    Wei Gao
    James Signorovitch
    Clemens Krepler
    Emilie Scherrer
    Jingshu Wang
    Raquel Aguiar-Ibáñez
    [J]. Clinical Drug Investigation, 2020, 40 : 629 - 643
  • [10] Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma
    Long, Georgina, V
    Luke, Jason J.
    Fukunaga-Kalabis, Mizuho
    Asierto, Paolo A.
    [J]. LANCET ONCOLOGY, 2023, 24 (01): : E8 - E8
12345